Employees: 03 (2023.0)Legal category: 5485Size: PMECreation date: 2017-02-09 (9 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: CARHAIX-PLOUGUER (29270), Finistere
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
PHARMACIE KER AHES : revenue, balance sheet and financial ratios
PHARMACIE KER AHES is a French company
founded 9 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in CARHAIX-PLOUGUER (29270),
this company of category PME
shows in 2023 a net income positive of 119 k€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - PHARMACIE KER AHES (SIREN 827580226)
Indicator
2023
2022
2021
2020
2019
2018
Revenue
N/C
N/C
N/C
N/C
N/C
N/C
Net income
119 055 €
218 688 €
320 871 €
147 048 €
494 373 €
69 274 €
EBITDA
N/C
N/C
N/C
N/C
N/C
N/C
Net margin
N/C
N/C
N/C
N/C
N/C
N/C
Revenue and income statement
In 2023, PHARMACIE KER AHES generates positive net income of 119 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2018-2023: 69 k€ -> 119 k€.
Net income (2023)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
119 055 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 80%. Debt level is high: negotiating margin with banks is reduced. Financial autonomy (= Equity / Total assets x 100) reaches 48%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Debt ratio (2023)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
80.289%
Financial autonomy (2023)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
48.379%
Asset age ratio (2023)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2018
2019
2020
2021
2022
2023
Debt ratio
746.45
178.221
264.588
142.621
99.879
80.289
Financial autonomy
9.526
29.389
23.275
36.753
44.22
48.379
Repayment capacity
None
None
None
None
None
None
Cash flow / Revenue
None%
None%
None%
None%
None%
None%
Sector positioning
Debt ratio
80.292023
2021
2022
2023
Q1: 20.09
Med: 66.92
Q3: 169.24
Average-8 pts over 3 years
In 2023, the debt ratio of PHARMACIE KER AHES (80.29) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
Financial autonomy
48.38%2023
2021
2022
2023
Q1: 28.72%
Med: 48.51%
Q3: 68.17%
Average+10 pts over 3 years
In 2023, the financial autonomy of PHARMACIE KER AHES (48.4%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 253.97. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2023)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
253.973
Liquidity indicators evolution PHARMACIE KER AHES
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2018
2019
2020
2021
2022
2023
Liquidity ratio
121.943
214.924
171.722
278.487
281.21
253.973
Interest coverage
None
None
None
None
None
None
Sector positioning
Liquidity ratio
253.972023
2021
2022
2023
Q1: 135.23
Med: 189.76
Q3: 270.17
Good
In 2023, the liquidity ratio of PHARMACIE KER AHES (253.97) ranks above the median of the sector. This ratio measures the ability to cover short-term debt with current assets. This comfortable position offers an appreciable safety margin.
Positioning of PHARMACIE KER AHES in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 220 transactions of similar company sales
in 2023,
the value of PHARMACIE KER AHES is estimated at
1 404 786 €
(range 854 317€ - 1 974 814€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2023
220 transactions
854k€1404k€1974k€
1 404 786 €Range: 854 317€ - 1 974 814€
NAF 5 année 2023
Valuation method used
Net Income Multiple
119 055 €
×
11.8x
=1 404 787 €
Range: 854 318€ - 1 974 815€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 220 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare PHARMACIE KER AHES with other companies in the same sector:
Frequently asked questions about PHARMACIE KER AHES
What is the revenue of PHARMACIE KER AHES ?
The revenue of PHARMACIE KER AHES is not publicly disclosed (confidential accounts filed with INPI).
Is PHARMACIE KER AHES profitable?
Yes, PHARMACIE KER AHES generated a net profit of 119 k€ in 2023.
Where is the headquarters of PHARMACIE KER AHES ?
The headquarters of PHARMACIE KER AHES is located in CARHAIX-PLOUGUER (29270), in the department Finistere.
Where to find the tax return of PHARMACIE KER AHES ?
The tax return of PHARMACIE KER AHES is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PHARMACIE KER AHES operate?
PHARMACIE KER AHES operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart